Skip to content

Innovative Training Methods for Frail Elderly in the Training Gain Stage

Effects of Whole Body Vibration With Stochastic Resonance and Exergames in the Elderly in Need of Care: Effects on Physical Functional Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01713790
Enrollment
40
Registered
2012-10-25
Start date
2012-10-31
Completion date
2015-04-30
Last updated
2015-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor Performance Status

Keywords

physical functional performance, postural balance, reaction time, mobility, muscle strength, cognition

Brief summary

This study aims to examine long term effects in the training gain stage of the falls management exercise programs (FaME, from Skelton and Dinan) over 10 weeks on physical functional performance after mechanical SR-WBV, dance therapy and strength training intervention in a frail elderly population.

Detailed description

This study is based on the guideline of falls management exercise programs (FaME; from Skelton and Dinan). The goals: Skilling up: improvement in neuromuscular control, postural control and strengthening of large muscle groups of the lower extremity. Training Gain: improvement of functional abilities. Maintaining the Gains: muscle growth, improvement of bone density and multi-sensory exercises. First, a pilot study was conducted with untrained elderly (Effects of stochastic resonance therapy on postural control in the elderly population (KEK Bern: No.228/09, Clinical Trial Registry: NCT01045746). Following, a second pilot study was conducted with frail elderly (Application of Whole-body Vibration With Stochastic Resonance in Frail Elderly: The Effects on Postural Control Clinical Trial Registry: NCT01543243). It was found that the selected chosen form of recruitment (presentation and advertisement) and the measurements methods are suitable for untrained elderly. But for frail elderly the chosen form of recruitment and the measurement methods are not sufficient. For this study, adapted measurement parameters for balance, strength and cognition will be used. The goals of this study: Evaluate the effects of * functional lower extremity * dynamic balance * reaction time * mobility * muscle strength and cognition. This is a one-group pre-post design study and the participants will be recruited in Canton Bern - Switzerland.

Interventions

DEVICEStochastic resonance whole-body vibration

Stochastic resonance whole-body vibration training program over 10 weeks, three times a week with 3 to 6 Hz, Noise 4.

DEVICEExergame

training program over 10 weeks, three times a week.

DEVICELeg press

training program over 10 weeks, three times a week.

Sponsors

Goethe University
CollaboratorOTHER
Maastricht University Medical Center
CollaboratorOTHER
Swiss Federal Institute of Technology
CollaboratorOTHER
Bern University of Applied Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* RAI (Resident Assessment Instrument) \>0 * live in canton Bern * in terms of training load be resistant.

Exclusion criteria

* acut joint disease, acut thrombosis, acute fractures, acute infections, acute tissue damage, or acute -- surgical scars * seniors with prosthesis. * alcoholic * acute joint disease, activated osteoarthritis, rheumatoid arthritis * acute inflammation or infection tumors * fresh surgical wounds * severe migraine * epilepsy * acute severe pain

Design outcomes

Primary

MeasureTime frameDescription
Short Physical Performance Battery (SPBB)Change from baseline in SPBB at 10 weeks.The SPBB assess lower extremity function at baseline and after a 10-week interventions period.

Secondary

MeasureTime frameDescription
dynamic body balanceChange from baseline in dynamic body balance at 10 weeks.The Expanded Timed Get Up-and-Go (ETGUG) will be used for measuring dynamic body balance. At 2, 8 and 10 meters along the walkway, markers were set. In the ETGUG test, times for the component tasks are measured at baseline and after a 10-week interventions period.
walking in single (ST) and dual task (DT) conditionsChange from baseline during walking in ST and DT condition at 10 weeks.1. For the single task condition, the participants will be instructed to walk a distance of 20 meters at their self-selected walking speed. Total time were measured. 2. For the dual task condition, the participant had to count backwards from the number 250 in steps of 7 while walking the same distance at their self-selected walking speed. Total walking times were measured. * The time differences between the two tasks are evaluated at baseline and after a 10-week interventions period.
mobilityChange from baseline in mobility at 10 weeks.The participants using a StepWatch ™ Activity Monitor (SAM) pedometer. This digital pedometer record the total daily steps at baseline and after a 10-week interventions period.
knee flexion rate of force develompent (RFD)Change from baseline in knee flexion RFD at 10 weeks.It will be evaluated by isometric RFD at 90 degree angle in the knee joint at baseline and after a 10-week interventions period.
knee extension rate of force develompent (RFD)Change from baseline in knee extension RFD at 10 weeks.It will be evaluated by isometric RFD at 90 degree angle in the knee joint at baseline and after a 10-week interventions period.
knee flexion maximum voluntary contraction (MVC)Change from baseline in knee flexion MVC at 10 weeks.It will be evaluated by isometric MVC at 90 degree angle in the knee joint at baseline and after a 10-week interventions period.
knee extension maximum voluntary contraction (MVC)Change from baseline in knee extension MVC at 10 weeks.It will be evaluated by isometric MVC at 90 degree angle in the knee joint at baseline and after a 10-week interventions period.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026